| 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) The … G Hindricks, T Potpara, N Dagres, E Arbelo, JJ Bax, ... European heart journal 42 (5), 373-498, 2021 | 10941 | 2021 |
| 2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiac monitoring/telemetry JS Steinberg, N Varma, I Cygankiewicz, P Aziz, P Balsam, A Baranchuk, ... Heart rhythm 14 (7), e55-e96, 2017 | 428 | 2017 |
| Acute heart failure congestion and perfusion status–impact of the clinical classification on in‐hospital and long‐term outcomes; insights from the ESC‐EORP‐HFA Heart Failure … O Chioncel, A Mebazaa, AP Maggioni, VP Harjola, G Rosano, C Laroche, ... European journal of heart failure 21 (11), 1338-1352, 2019 | 273 | 2019 |
| In‐hospital and 1‐year mortality associated with diabetes in patients with acute heart failure: results from the ESC‐HFA Heart Failure Long‐Term Registry G Targher, M Dauriz, C Laroche, PL Temporelli, M Hassanein, ... European journal of heart failure 19 (1), 54-65, 2017 | 176 | 2017 |
| Performance of prognostic risk scores in chronic heart failure patients enrolled in the European Society of Cardiology Heart Failure Long-Term Registry M Canepa, C Fonseca, O Chioncel, C Laroche, MG Crespo-Leiro, ... JACC: Heart Failure 6 (6), 452-462, 2018 | 151 | 2018 |
| Unravelling the interplay between hyperkalaemia, renin–angiotensin–aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC‐HFA … P Rossignol, M Lainscak, MG Crespo‐Leiro, C Laroche, MF Piepoli, ... European journal of heart failure 22 (8), 1378-1389, 2020 | 125 | 2020 |
| Sex‐and age‐related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long‐Term Registry M Lainščak, I Milinković, M Polovina, MG Crespo‐Leiro, LH Lund, ... European journal of heart failure 22 (1), 92-102, 2020 | 106 | 2020 |
| Relation of outcomes to ABC (Atrial Fibrillation Better Care) pathway adherent care in European patients with atrial fibrillation: an analysis from the ESC-EHRA EORP Atrial … M Proietti, GYH Lip, C Laroche, L Fauchier, F Marin, M Nabauer, ... EP Europace 23 (2), 174-183, 2021 | 101 | 2021 |
| Cardiac arrhythmias in autoimmune diseases M Gawałko, P Balsam, P Lodziński, M Grabowski, B Krzowski, G Opolski, ... Circulation Journal 84 (5), 685-694, 2020 | 89 | 2020 |
| A comprehensive characterization of acute heart failure with preserved versus mildly reduced versus reduced ejection fraction–insights from the ESC‐HFA EORP Heart Failure Long … A Kapłon‐Cieślicka, L Benson, O Chioncel, MG Crespo‐Leiro, AJS Coats, ... European Journal of Heart Failure 24 (2), 335-350, 2022 | 87 | 2022 |
| Kardia Mobile applicability in clinical practice: A comparison of Kardia Mobile and standard 12-lead electrocardiogram records in 100 consecutive patients of a tertiary … L Koltowski, P Balsam, R Glowczynska, JK Rokicki, M Peller, J Maksym, ... Cardiology journal 28 (4), 543-548, 2021 | 85 | 2021 |
| Influence of beta-blockers on endothelial function: a meta-analysis of randomized controlled trials M Peller, K Ozierański, P Balsam, M Grabowski, KJ Filipiak, G Opolski Cardiology journal 22 (6), 708-716, 2015 | 79 | 2015 |
| Association between antithrombotic treatment and outcomes at 1-year follow-up in patients with atrial fibrillation: the EORP-AF General Long-Term Registry G Boriani, M Proietti, C Laroche, L Fauchier, F Marin, M Nabauer, ... EP Europace 21 (7), 1013-1022, 2019 | 74 | 2019 |
| Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction: GALACTIC‐HF baseline characteristics and comparison with contemporary clinical trials JR Teerlink, R Diaz, GM Felker, JJV McMurray, M Metra, SD Solomon, ... European journal of heart failure 22 (11), 2160-2171, 2020 | 60 | 2020 |
| Safety of pulsed field ablation in more than 17,000 patients with atrial fibrillation in the MANIFEST-17K study E Ekanem, P Neuzil, T Reichlin, J Kautzner, P van der Voort, P Jais, ... Nature medicine 30 (7), 2020-2029, 2024 | 58 | 2024 |
| Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc … S Verma, NK Dhingra, J Butler, SD Anker, JP Ferreira, G Filippatos, ... The Lancet Diabetes & Endocrinology 10 (1), 35-45, 2022 | 58 | 2022 |
| Body surface area as a prognostic marker in chronic heart failure patients: results from the Heart Failure Registry of the Heart Failure Association of the European Society of … B Zafrir, N Salman, MG Crespo‐Leiro, SD Anker, AJ Coats, R Ferrari, ... European journal of heart failure 18 (7), 859-868, 2016 | 56 | 2016 |
| Predictors of one-year outcome in patients hospitalised for heart failure: results from the Polish part of the Heart Failure Pilot Survey of the European Society of Cardiology P Balsam, A Tymińska, A Kapłon-Cieślicka, K Ozierański, M Peller, ... Polish Heart Journal (Kardiologia Polska) 74 (1), 9-17, 2016 | 55 | 2016 |
| OCULUS study: Virtual reality-based education in daily clinical practice P Balsam, S Borodzicz, K Malesa, D Puchta, A Tymińska, K Ozierański, ... Cardiology journal 26 (3), 260-264, 2019 | 50 | 2019 |
| Sacubitril/valsartan eligibility and outcomes in the ESC‐EORP‐HFA Heart Failure Long‐Term Registry: bridging between European Medicines Agency/Food and Drug Administration … CJ Kapelios, M Lainscak, G Savarese, C Laroche, P Seferovic, ... European journal of heart failure 21 (11), 1383-1397, 2019 | 45 | 2019 |
Michał PellerMedical University of WarsawVerified email at wum.edu.pl